**Star Imaging and Path Lab Limited** is an India-based diagnostic and healthcare services provider, operating across pathology, radiology, cardiology, and neurology segments under a NABL-accredited network. Originally a proprietorship founded in 1978 under the name Janta X-Ray Clinic, the company transitioned to a private limited entity in 2004 and further converted to a public limited company in 2024. Its business model integrates significant advancements in diagnostic technologies, offering comprehensive diagnostic solutions including routine and specialized tests pivotal for disease detection, screening, monitoring, and treatment outcomes.
The company's services cover a wide spectrum of diagnostic imaging (X-ray, CT, MRI, ultrasound, mammography, etc.) alongside clinical laboratory specialties like biochemistry, hematology, histopathology, microbiology, and immunology. It has expanded operations under both B2C and B2G models in regions such as Delhi, Uttar Pradesh, and Nasik. In addition to its brick-and-mortar network, Star Imaging also operates a tele-radiology hub, utilizing advanced imaging equipment and specialized radiologists to deliver consistent, quality diagnostic services with operational scalability.
Expansion efforts include the acquisition of businesses like Janta X-Ray Clinic and Star Health Care in 2011 and the launch of a subsidiary, Staredu Education and Training Institute Private Limited, in 2017 to diversify business activities. The company’s aim of ensuring progressive patient care and operational excellence is supported by a centralized approach to diagnostics.
Star Imaging and Path Lab Limited is planning an IPO of 48.92 lakh equity shares, including a fresh issue of 39.20 lakh shares and an offer for sale of 9.72 lakh shares. This IPO will likely support its expansion efforts, offering traders an opportunity to invest in a healthcare enterprise with a history of innovation and growth.
